These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5590084)

  • 21. [10 percent diammaglobulins in O.R.L. (Study of 12 cases)].
    Villedrouin J; Prache H; Leroux-Robert J
    Ann Otolaryngol Chir Cervicofac; 1966 Dec; 83(12):869-74. PubMed ID: 4166230
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is beclomethasone dipropionate a gain in the therapy of chronic rhinopathy?].
    Clement PA; Pauwels HP
    Acta Otorhinolaryngol Belg; 1980; 34(5):547-55. PubMed ID: 7468201
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical use of bromelain (Ananase) in chronic rhino-sinusitis].
    Hine S; Tamura N
    Jibiinkoka; 1966 Apr; 38(4):439-42. PubMed ID: 5335479
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical evaluation of sulfarinol and rhinophenazol used in acute, chronic and allergic rhinitis].
    Radzimiński A; Latkowski B; Laciak J
    Pol Tyg Lek; 1966 Jul; 21(28):1076-8. PubMed ID: 5338583
    [No Abstract]   [Full Text] [Related]  

  • 25. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
    Kramer MF; Ostertag P; Pfrogner E; Rasp G
    Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Steroid sprays in non-infectious rhinitis and sinusitis. Proper and regular spraying does not damage the nasal mucosa].
    Klimek L; Bachert C; Hörmann K
    MMW Fortschr Med; 2002 Mar; 144(10):41-3. PubMed ID: 11928263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical issues relating to intranasal steroid therapy.
    Tan LK
    Singapore Med J; 2002 Aug; 43(8):412-4. PubMed ID: 12507027
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute rhinosinusitis and systemic corticosteroids.
    Ukwaja KN
    CMAJ; 2013 Jan; 185(1):62. PubMed ID: 23297139
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of the efficacy and tolerance of prednisolone versus niflumic acid in the treatment of acute sinusitis in adults].
    Cannoni M; Sambuc R; San Marco JL; Auquier P; Gorget C; Chiarelli P
    Ann Otolaryngol Chir Cervicofac; 1990; 107(4):276-81. PubMed ID: 2221720
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute rhinosinusitis and systemic corticosteroids--response to Ukwaja.
    Venekamp RP
    CMAJ; 2013 Jan; 185(1):62. PubMed ID: 23297140
    [No Abstract]   [Full Text] [Related]  

  • 32. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience with the HS-592 in the dysreactive, allergy and exudative processes in E.N.T].
    Sánchez García J
    Acta Otorinolaryngol Iber Am; 1969; 20(6):645-57. PubMed ID: 4393808
    [No Abstract]   [Full Text] [Related]  

  • 34. Corticoid fundamentals in treatment of ear, nose and throat allergy.
    Rawlins AG
    Ann Allergy; 1966 Oct; 24(10):560-3. PubMed ID: 5921708
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic value of HS-592 preparation in the light of clinical and experimental studies].
    Semczuk B; Czerwonka R; Klos A
    Otolaryngol Pol; 1971; 25(2):179-85. PubMed ID: 5577921
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of allergic rhinitis associated with hypothyroidism].
    Gamzatova AA; Gadzhimirzaev GA; Abusuev SA; Gamzatova EG
    Vestn Otorinolaringol; 2006; (6):34-7. PubMed ID: 17419501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the treatment of rhinitis].
    Zacharias W
    Landarzt; 1966 Apr; 42(12):534-8. PubMed ID: 5953867
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study.
    Ural A; Oktemer TK; Kizil Y; Ileri F; Uslu S
    J Laryngol Otol; 2009 May; 123(5):517-21. PubMed ID: 18957157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis.
    Dolovich J; Moote DW; Mazza JA; Clermont A; PetitClerc C; Danzig M
    Ann Allergy; 1994 Sep; 73(3):235-9. PubMed ID: 8092558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A double-blind, placebo-controlled study on the efficacy of Rinasek in symptomatic treatment of seasonal and non-seasonal rhinitis].
    Udovicki J; Milosevic D; Popov-Dragin O
    Med Pregl; 1995; 48(7-8):255-9. PubMed ID: 8524201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.